Hematological and biochemical status of Beta-thalassemia major patients in Bangladesh: A comparative analysis
Abstract
Background: Thalassemia is one of the most common hereditary disorders and Beta-thalassemia major is its severe form. The present study is concerned with the analysis of liver function, thyroid function and estimation of critical serum ions as well as hematological characteristics in beta-thalassemia patients and controls.
Subjects and Methods: The study included 54 patients with beta-thalassemia major and 54 healthy individuals matched by sex and age. The activity of Alanine transaminase (ALT), Alkaline phosphatase(ALP) and Aspartate transaminase (AST) were assessed in order to evaluate the liver function. Serum content of iron (Fe), calcium (Ca), magnesium (Mg), sodium (Na) and potassium (K) were also estimated. Tri iodothyronine (T3), Thyroxin (T4) and Thyroid-stimulating hormone (TSH) levels were assessed in order to evaluate the thyroid function. Hemoglobin (Hb), ferritin, hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration(MCHC), total iron binding capacity (TIBC) and creatinine level were also measured.
Results: Significantly higher ALT (P< 0.001), AST (P< 0.05), ALP (P< 0.001) activities and lower creatinine (P< 0.001) level in beta-thalassemia patients were found in comparison to healthy individuals. Lower serum level of calcium (P<0.05), magnesium (P<0.05) and higher level of iron (P>0.05), sodium (P>0.05), potassium (P>0.05) have been found in patients in comparison to healthy individuals. Hematological parameters like Hb (P< 0.001), ferritin (P<0.05), HCT (P< 0.001), MCV (P< 0.05) and MCH (P< 0.05) have been significantly reduced in patients except MCHC (P>0.05). No significant difference was observed in thyroid function between patients and control group.
Conclusions: Our study demonstrates that beta-thalassemia patients and controls have difference in liver function, thyroid function, serum contents of ions and hematological characteristics.
Desouky OS, Selim NS, El-Barawy EM, et al. Biophysical characterization of β-thalassemic red blood cells. Cell Biochem Biophys.2009; 55: 45–53.
Omar A, Abdel Karim E, Gendy WE, et al. Molecular basis of ß-thalassemia in Alexandria. Egypt J Immunol, 2005; 12: 15–24.
Ferdaus MZ, Hasan AK, Shekhar HU. Analysis of serum lipid profiles, metal ions and thyroid hormones levels abnormalities in β-thalassaemic children of Bangladesh. JPMA. J Pak Med Assoc. 2010; 60: 360.
De Sanctis V, Pinamonti A, Di Palma A, et al. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr. 1996; 155: 368-372.
Low LC. Growth of children with β-thalassemia major. Indian J Pediatr. 2005; 72: 159-164.
Soliman AT, elZalabany MM, Mazloum Y, et al. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IFG-I) concentration in patients with beta thalassaemia and delayed growth. J Trop Pediatr. 1999; 45: 327-337.
Gulati R; Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in ß-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000; 13: 651-656.
Swasan S, Sarab H, Ali T. Iron overload and endocrine pattern in children with thalassemia syndromes. Iraqi J. Medi. Sci. 2001; 1:159-168.
Al-Samarrai AH, Adaay MH, Al-Tikriti KA, et al. Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq. Saudi Med J. 2008; 29: 94.
Cario H, Stahnke K, Kohne E. Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study. Klin Padiatr. 1998; 211: 431-437.
Ambu R, Crisponi G, Sciot R, et al. Uneven hepatic iron and phosphorous distribution in beta-thalassemia. J Hepatol. 1995; 23:544–9.
Widad NM, Al-Naama L, Meaad KH. Trace element in patients with beta thalassemia major. Haem. 2003; 6: 376-83.
Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006; 37: 12-20.
Rund D, Rachmilewitz E. Beta-thalassemia. Engl J Med. 2005; 353: 1135-1146.
Origa R, Bina P, Agus A, et al. Combined therapy with deferiprone and desferrioxamine in thalassemia major. Haematologica. 2005; 90(10): 1309-14.
Kwan EY, Lee AC, Li AM, et al. A cross-sectional study of growth, puberty and endocrine fuction in patients with thalassaemia major in Hong Kong. J Paediatr Child Health. 1995; 31: 83-87.
Mahmoodi MR, Kimiagar SM. Prevalence of zinc deficiency in junior highschool students of Tehran City. Biol Trace Elem Res. 2001; 81: 93-103.
Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem. 1965; 8: 140–187.
Alaa-Eldin Salah-Eldin. Practical Hematology manual. Zolfi College of Science, Department of Medical Laboratories.
Varley H. Ramasays Dipyridyl method for total ironbinding capacity. In Practical Clinical Biochemistry. 1967; 4th Edition: 475.
Mazzachi RD, Mazzachiand BC, Berry MN. A Manual Spectrophotometric Method for the Measurement of Serum Sodium and Potassium by Enzyme Activation. Eur J Clin Chem Clin Biochem. 1994; 32:709-717.
Jacobs A, Miller F, Worwood M. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. BMJ. 1972; 4: 206.
Aleem A, Al-Momen AK, Al-Harakati MS, et al. Hypocalcemia due to hypoparathyroidism in beta-thalassemia major patients. Ann Saudi Med. 2000; 20: 364-366.
Abdalla M, Fawzi M, Salem R, et al. Increased oxidative stress and iron overload in jordanian β-thaassemic children. Hemoglobin. 2011; 35:67–79.
Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with ß-Thalassemia Major. J Pediatr Endocrinol Metab. 2003; 16: 883-886.
Kontessis P, Mayopoulou-Symvoulidis D, Symvoulidis A, et al. Renal involvement in sickle cell-beta thalassemia. Nephron. 1992; 61: 10-15.
Mol A and M Berg. Principles and practices of medicine. Culture, Medicine and Psychiatry. 1994; 18: 247-265.
Beutler E, Felitti V, Gelbart T, et al. Genetics of iron storage and hemochromatosis. Drug Metab Dispos. 2001; 29: 495-499.
Joiner CH. Cation transport and volume regulation in sickle red blood cells. Am J Physiol. 1993; 264: 251-270.
Rahul AG, Kumbar KM, Suryakar AN, et al. Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian J Clin Biochem. 2008; 23: 337-340.
Simsek F, Ozturk G, Kemahl S, et al. Oxidant and antioxidant status in beta thalassemia major patients. Ankara Universitesi Tıp Fakultesi Mecmuas. 2005; 58:34-38.
Attia MMA, Sayed AM, Ibrahim FA, et al. Effects of antioxidant vitamins on the oxidant/antioxidant status and liver function in homozygous beta-thalassemia. ROMANIAN J. BIOPHYS. 2011; 21: 93-106.
El-Hazmi MAF, Al-Swailem A, Al-Fawaz I, et al. Diabetes mellitus in children suffering from β-thalassaemia. J Trop Pediatr. 1994; 40: 261-266.
Bahar A, Kashi Z, Sohrab M, et al. Relationship between beta-globin gene carrier state and insulin resistance. J Diabetes Metab disorder. 2012; 11: 22.
Al-Quobaili FA, Abou Asali IE. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Saudi Med J. 2004; 25: 871-875.
Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29: 233-238.
Phumala N, Porasuphatana S, Unchern S. Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia/hemoglobin E disease. Free Radic Res. 2003; 37: 129–35.
Weatherall DJ, Clegg JB. Thalassemia revised. Cell. 1982; 29: 7–9.
Petkov GH, Efremov GD, Efremov DG, et al. Beta-thalassemiain Bulgaria. Hemoglobin. 1990; 14: 25–33.
Ghavamzadeh A, Jahani M, Baybordi E. Bone marrow transplantation in Iran. Bone marrow transplantation. 1994; 13: 743-744.
Zakerinia M, Khojasteh HN, Ramzi M, et al. Bone marrow transplantation in thalassemia major patients using “short” anti-thymocyte globulin therapy in Shiraz, Southern Iran. Transplant Proc. 2005; 37:4477-81.
| Files | ||
| Issue | Vol 10, No 1 (2016) | |
| Section | Articles | |
| Keywords | ||
| Beta-thalassemia major Liver function Thyroid function Hematological characteristics | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
